INTRODUCTION AND OBJECTIVES:
We performed a prospective, randomized trial to assess the safety and efficacy of Tisseelâ, Tachosilâ in tubeless percutaneous nephrolithotomy.
METHODS: A total of 75 patients undergoing tubeless percutaneous nephrolithotomy(PCNL) were randomized to receive Tisseelâ, Tachosilâ and control at the end of the procedure. The three groups were comparable in age, sex, height, weight, body mass index, stone size and in metabolic and anatomic features. (Table 1) After stone clearance, at the end of the procedure, the nephrostomy tract was closed with a deep #1-0 silk stitch in group 1 patients. Tisseel sealant was loaded and introduced into nephrostomy tract in group 2 patients. In group 3 patients, Tachosil was dipped in contrast medium, rolled like a cigarette and inserted through the nephrostomy tract. The primary end of this study was to evaluate the efficacy of sealants in PCNL. And, the secondary end was compliance of sealants by pain and hospital stay.
RESULTS: There were no differences in the hemoglobin decrease and blood transfusion requirement among the groups during the operation. (Table 2 ) Serial changes in hemoglobin were comparable among the groups during the hospital stay. (Table 3) There was no significant difference in the extent of postoperative perirenal hematoma formation. (p¼0.694) (Table 4) The average visual analog scale pain score on postoperative 1 day were 1.92AE2.47, 1.72AE1.67 and 1.48AE1.73 respectively in each group. (p¼0.378) The hospital stay were 2.28AE0.93, 2.00AE0.96, and 2.04AE0.99 (p¼0.579) in each group. No long-term sequelae were observed in the median follow up period of 24 months in any patient.
CONCLUSIONS: This study indicates that the hemostatic agents in standard tubeless PCNL were not expected to be effective or mandatory. Additional wide, prospective, randomized studies are required to get more fine clinical evidence for the hemostatic agent usage in tubeless PCNL. 
There is no consensus for the term "staghorn calculi", "partial" or "complete", are designations that do not imply any volume judgment. "Staghorn morphometry", is defined as the stone volumetric burden distribution in the collecting system. Objective. Determine "stone morphometry" by preoperative computed tomography (CT).
METHODS: Retrospective-analytical study. 46 patients, 2012-2016, CT at all. Using OsiriX Software, measurement of: Total stone volume (TSV: volume calculated with the reconstruction of the entire image of the stone), entry calix stone volume (ECSV: component of stone in entry calix), favorable calix stone volume (FCSV: component of stone in favorable calix).
RESULTS: It was observe: TSV: 2753 AE 1423 mm3 and 56867 AE 26781 mm3 (p¼<0,001), ECSV: 580 AE 474 mm3 and 17586 AE 13150 mm3 (p¼<0,001), FCSV: 589 AE 569 mm3 and 17900 AE 13717 mm3 (p¼<0,001), in cases with single and those with ! 2 tracts, respectively. TSV >5000 mm3, has 8 and 60 times greater risk for !2 stages and/or tracts, necessaries for stone free rates (CI 95: 2, 16 and 9, 16) .
CONCLUSIONS: Stone morphometry, provides the volumetric stone distribution to be treated, and significantly influences to determine the number of tracts and/or stages necessary to achieve a stone free rate in patients with staghorn calculi who underwent percutaneous nephrolithotomy.
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